Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Myricitrin
Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020
Icariin
Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020
1-(3-Methoxy-4-hydroxyphenyl)-5-hydroxy-7-(3,4-dihydroxyphenyl)-3-heptanone
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Sophaline D
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Thalimonine
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
(-)-beta-Sesquiphellandrene
Potential treatment - theoretical effect Natural product Antiviral Nov/27/2020
Piperolactam A
Potential treatment - theoretical effect Natural product Antiviral Jan/28/2021
Colossolactone G
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Robinetin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Wogonin
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Gartanin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Callophycin A
Potential treatment - theoretical effect Natural product Antiviral Nov/21/2020
Colossolactone E
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Morin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Colossolactone VIII
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
[1-(3,5-Dihydroxyphenyl)-12-hydroxytridecan-2-yl] acetate
Potential treatment - theoretical effect Natural product Antiviral Aug/14/2020
Kazinol J
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
Velutin
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Hinokiflavone
Potential treatment - theoretical effect Natural product Antiviral Feb/04/2021
18-Hydroxy-3-epi-alpha-yohimbine
Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020